Thoracic Surgery Clinical Trial
Official title:
Prospective, Randomized Study of the Effects of Pressure-controlled vs. Volume-controlled Ventilation During One Lung Ventilation on Lung Injury After Thoracotomy
Compared with the information available in sepsis and trauma-associated ARDS, less is known
about the cause and pattern of lung injury after thoracic surgery. Definition of lung injury
in this context is difficult. Most now use the joint North American-European consensus
conference definitions, but these are based only on gas exchange and radiology criteria.
While gas exchange measures are reliable, thoracotomy inevitably causes radiological change
and the interpretation of plain chest films becomes subjective. Definitions based on
permeability and inflammatory changes would improve diagnosis, but are not routinely
available in most units.
Pressure-controlled volume (PCV) may be useful to improve gas exchange and alveolar
recruitment with associated lower airway pressures and shunt fraction during one-lung
ventilation (OLV).
However, a recent prospective randomized study of the effects of PCV during OLV did not lead
to improved oxygenation during OLV compared with VCV, but PCV did lead to lower peak airway
pressures. To date, there are no reports of the effects of PCV versus VCV during OLV on the
acute lung injury (ALI) after thoracotomy.
Project Objectives:
We hypothesize that the use of PCV during OLV for thoracic surgery may improve the
anti-inflammatory immunoregulation than VCV. It may attenuate the increases in
proinflammatory cytokines, including interleukins (IL-8, IL-1, and IL-6) and TNF-α, and
prevent suppression of the anti-inflammatory cytokine (IL-10) secretion.
The aims of the present study are:
Our research efforts will focus on identifying the effects of PCV vs.VCV during OLV for
thoracotomy on the followings.
1. Intraoperative changes in the peak and plateau airway pressures and static and dynamic
lung compliance.
2. Pulmonary function tests [vital capacity and FEV1] and arterial blood gases changes
during the first 3 postoperative days.
3. The perioperative changes in serum levels of the proinflammatory cytokines, including
IL-1, IL-6, IL8, and TNF-α and the anti-inflammatory cytokines IL-10,
4. The perioperative changes in BAL levels of the concentration of proteins, IL-1, IL-6,
IL8, IL-10, and TNF-α.
5. The duration of postoperative ventilatory support, the time to extubation, the length of
stay in post-anaesthesia care unit (PACU).
6. The incidence of the major complications (respiratory failure, cardiovascular events,
bleeding, and renal dysfunction).
Project Design:
Study Design:
This prospective randomized placebo-controlled blinded study will be carried out from at the
Cardiothoracic Surgery Unit - King Fahd University Hospital, after approval of the
Institutional Ethical Committee.
Study Phases: The project comprised of five phases as follow:
• Phase I: Literature review collection and writing which will spend 2 months.
• Phase II: Pilot Study for 2 months to determine changes in the serum levels of cytokines to
test the power of the study to define the proper sample size for both the VCV and PCV group
during OLV.
• Phase III: A. Thoracic procedures using one-ling ventilation techniques: Arterial blood
gases, chest X- ray, pulmonary function tests, liver function tests, CPK, samples collection
[serum and BAL] and laboratory testing for cytokine changes.
B. Recording of the Clinical Outcome: included the times of ventilation, extubation, ICU and
hospital stay, mortality and morbidity.
Sampling Site:
The study will be conducted in the OR suite and ICU at the King Fahd Hospital of the
University - Alkhubar Study period: For 6 months. I. Patient Selection: patients aged 18-60
years (ASA physical status II-III) scheduled for elective open thoracic surgery using one
lung ventilation for periods longer than 1.5 h will be allocated randomly to two groups by
drawing of sequentially numbered sealed opaque envelopes that each contained a
computer-generated randomization code. We will exclude the patients with decompensated
cardiac (>New York Heart Association II), pulmonary diseases (VC or FEV1<50% of the predicted
values), pulmonary hypertension (mean pulmonary artery pressure [MPAP] >30 mm Hg), and
previous lobectomy or bilobectomy in the medical history, those treated with immune
modulators (cytostatic drugs, corticosteroids and non-steroidal anti-inflammatory drugs,
vaccination, blood products), within 3 months before surgery and with symptoms of an acute
inflammatory process (clinically defined or abnormal data for C-reactive protein, leukocyte
count, or body temperature).
II. Patient Groups and Study Protocol: Volume-controlled ventilation [VCV] group (n=according
to the power of the study): patients' lungs will ventilated with a tidal volume of 8 ml.kg-1.
Pressure-controlled ventilation [PCV] group (n=as before) patients' lungs ventilation will be
initiated with a peak airway pressure that provided a tidal volume of 8 ml.kg-1. R.R will be
adjusted to achieve an arterial PaCO2 4.5-6 kPa and FiO2 will be increased to 1.0 during OLV.
All staff in the operating room, ICU and the ward will be unaware of the randomization code.
III. Anesthesia and Surgery: The patients will undergo combined thoracic epidural analgesia
and general anesthesia using one lung ventilation technique for open thoracic surgical
procedures through a standard posterolateral or an anterolateral muscle-sparing thoracotomy
by the same consultants.
IV. The Investigators who will be involved with subsequent postoperative patient assessment
will be blinded of the patient group.
V. Clinical Examination: included the intraoperative changes in airway pressures and lung
compliances and the perioperative changes in pulmonary function tests [vital capacity and
FEV1], the duration of postoperative ventilatory support, the time to extubation, the length
of stay in PACU, the incidence of any major complications (respiratory failure,
cardiovascular events, bleeding, and renal dysfunction).
VI. Blood Biochemistry: included the perioperative changes in arterial blood gases.
VII. Samples Collection and Analysis For the Inflammatory Mediators: The perioperative
changes in serum levels of the concentration of the cytokines IL-1, IL-6, IL8, IL-10, and
TNF-α, and the perioperative changes in BAL levels of the concentration of proteins, IL-1,
IL-6, IL8, IL-10, and TNF-α.
1. . Type of samples: centrifuged stored aliquots of serum at -70°C and Supernatant frozen
(at -80°C) broncho-alveolar lavage (BAL) aliquots.
2. . Laboratory Analysis:
1. Cytokine determinations on the BAL fluid and plasma will be carried out using a
solid-phase enzyme-linked immunosorbent assay method based on the quantitative
immunometric sandwich enzyme immunoassay technique (Quantikine®; R&D Systems Ltd.,
Abingdon, UK).
2. TNF-α immunoassay will be provided by Immunotech, France. Protein concentrations
will be measured by an assay for the colorimetric detection and quantitation of
total protein (Micro BCA TM Protein Assay Reagent Kit; Pierce, Rockford, IL).
3. All samples of one patient will be analyzed in the same assay run.
4. The samples will be measured in duplicates and the assays will be performed
according to the manufacturer's instructions.
5. The optical density of the samples will be determined by a microplate reader
(Safire®; Tecan Ltd., Salzburg, Austria) and will be analyzed using the Safire
microplate reader software by interpolation from standard curves. The sensitivities
of the test kits are as follows: IL-1: 10 pg.mL-1, IL-6: 10 pg.mL-1, IL-8: 3.5
pg.mL-1, IL-10: 0.5 pg.mL-1, TNF : 5 pg.mL-1, protein: 0.5 µg.mL-1.
IV. Statistical Analysis: 2months Statistical analysis will be performed using the
Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL). Data will be tested for
normality using Kolmogorov-Smirnov test. An unpaired Student's t test will be used to compare
the parametric values of the two groups; Mann-Whitney U test will be performed to compare the
non-parametric values of the two groups. Serial changes in peri-operative data at the start
of the treatment will be analyzed with repeated measures analysis of variance. PFTs variables
and cytokine changes at different times within groups will be analysed with repeated measure
analysis of variance (Anova test). Data will be expressed as mean (SD), number (%) or (median
[range]). A value of P<0.05 will be considered to represent statistical significance.
V.Report Writing:2 months
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04865874 -
GDT-PPV Protocol in Thoracic Surgery
|
N/A | |
Active, not recruiting |
NCT02715271 -
Study of TB Lesions Obtained in Therapeutical Surgery
|
||
Completed |
NCT02919267 -
Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms
|
N/A | |
Completed |
NCT02964026 -
Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients
|
N/A | |
Recruiting |
NCT03165539 -
Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
|
||
Terminated |
NCT01320475 -
Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine
|
Phase 4 | |
Recruiting |
NCT05045196 -
Health-promoting Family Conversations and Open Heart Surgery
|
N/A | |
Completed |
NCT04507958 -
Electronic Stethoscope Use During Intubation in Full Personal Protective Equipment
|
||
Recruiting |
NCT05060302 -
Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery
|
N/A | |
Completed |
NCT05667467 -
The Effect of Care Bundle in Heart Surgery
|
N/A | |
Not yet recruiting |
NCT03275428 -
THRIVE and Non-intubated Thoracic Surgery
|
N/A | |
Not yet recruiting |
NCT05482230 -
Application of Tracheal Intubation in Lateral Position in Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT04429009 -
A Randomized Control Trial of ZEPHYRx Gamified Incentive Spirometry Compared to Traditional Spirometry
|
N/A | |
Not yet recruiting |
NCT03628040 -
Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery
|
Phase 3 | |
Recruiting |
NCT03300622 -
Assessment in Patients After Thoracic Surgery
|
N/A | |
Completed |
NCT00981474 -
Cerebral Autoregulation Monitoring During Cardiac Surgery
|
N/A | |
Completed |
NCT03309280 -
Influence of Different Parameters on Extubation Time After Cardiac Surgery.
|
||
Recruiting |
NCT03820700 -
Using Hypnosis and Virtual Reality During Pre and Postoperative Cardiovascular Surgery.
|
N/A | |
Completed |
NCT03768193 -
Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery
|
N/A | |
Recruiting |
NCT04609228 -
Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
|